Brain training may tame migraines without drugs
NCT ID NCT07661888
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether neurofeedback—a type of brainwave training—can help adults with episodic migraine have fewer and less severe headaches. Participants will undergo 60 sessions over 12 weeks, learning to regulate their brain activity through real-time feedback. The goal is to see if this non-drug approach can reduce migraine frequency, severity, and reliance on medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Neurofeedback (EEG-based brainwave training and blood volume pulse biofeedback)
What this could lead to
If effective, neurofeedback could offer a drug-free way to reduce migraine attacks and improve quality of life for people with episodic migraine.
What could go wrong
This is a small, early-stage trial with 66 participants, and results may not apply to everyone. The intensive 60-session schedule may be hard to maintain, and benefits may not last long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPISODIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Salamanca
Salamanca, Salamanca, 37007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••